Francois Nader

Type: Person
Name: Francois Nader
First reported Sep 15 2014 - Updated Sep 16 2014 - 2 reports

NPS Pharma Hormone Drug Wins Shaky Endorsement From FDA Panel

09/15/14 - 09:32 AM EDTBEDMINSTER, NJ ( TheStreet ) -- NPS Pharmaceuticals ( NPSP ) shares are down 11% in early Monday trading following a rough outing for its hormone replacement therapy Natpara at an FDA advisory panel on Friday.Independent experts ... [Published TheStreet.com - Sep 15 2014]
First reported Sep 12 2014 - Updated Sep 13 2014 - 3 reports

FDA Advisory Committee Recommends Approval of Natpara® for Long-Term Treatment of Hypoparathyroidism

NPS Pharma to host conference call today at 5:30 PM EDTPDUFA date for Natpara BLA is October 24, 2014BEDMINSTER, NJ, USA I September 12, 2014 I NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), a global biopharmaceutical company pioneering and delivering therapies ... [Published PipelineReview - Sep 13 2014]
First reported Sep 11 2014 - Updated Sep 11 2014 - 1 reports

NPS Pharmaceuticals Inc. (NPSP) Jumps 25.11% on September 10

NPS Pharmaceuticals Inc. ( NPSP ) was among the biggest gainers on the Russell 2000 for September 10 as the stock popped 25.11% to $32.24, representing a gain of $6.47 per share. Some 10,688,065 shares traded hands on 49,784 trades, compared with an ... [Published Equities.com - Sep 11 2014]
First reported Sep 10 2014 - Updated Sep 10 2014 - 1 reports

NPS jumps as FDA reviewers take little issue with orphan drug

NPS CEO Francois NaderNPS Pharma ($NPSP) is moving toward FDA approval with its treatment for a rare disease, as agency staff applauded the drug's efficacy ahead of a make-or-break panel vote.The treatment, dubbed Natpara, replaces human parathyroid hormone ... [Published FierceBiotech - Sep 10 2014]
First reported Sep 03 2014 - Updated Sep 03 2014 - 1 reports

NPS Pharma: Important Catalyst Coming Next Week

Summary NPS Pharmaceuticals has been very volatile this year and the stock is almost flat since the year started. Gattex sales are ramping up and Q2 revenue was ahead of estimates. The AdCom meeting is coming up next week and should serve as a big ... [Published Seeking Alpha - Sep 03 2014]
First reported May 08 2014 - Updated May 08 2014 - 1 reports

NPS Pharma Blames Winter, Drug Stops for Weak First Quarter, Reduced Guidance

NPS Pharmaceuticals reported first-quarter net sales of Gattex totaling $17.9 million, a consensus miss which the company blames on bad winter weather and a rise in the number of patients discontinuing therapy. The slow start to the year means NPS Pharma ... [Published The Street Latest - May 08 2014]
First reported Mar 26 2014 - Updated Mar 26 2014 - 1 reports

Clementia Pharmaceuticals Inc. Appoints Francois Nader, M.D. to Board of Directors

Healthcare Industry Veteran Brings Deep Expertise in Developing Innovative Therapies for Patients With Rare Diseases ... [Published Marketwire - Breaking News Releases - Mar 26 2014]

More Content

All (11) | News (10) | Reports (0) | Blogs (1) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
NPS Pharma Hormone Drug Wins Shaky Endorsement ... [Published TheStreet.com - Sep 15 2014]
NPS Pharma Hormone Drug Wins Shaky Endorsement ... [Published The Street Latest - Sep 15 2014]
FDA Advisory Committee Recommends Approval of N... [Published PipelineReview - Sep 13 2014]
CORRECTING AND REPLACING/ FDA Advisory Committe... [Published Scottrade - Sep 12 2014]
FDA Advisory Committee Recommends Approval of N... [Published Investor's Business Daily - Sep 12 2014]
NPS Pharmaceuticals Inc. (NPSP) Jumps 25.11% on... [Published Equities.com - Sep 11 2014]
NPS jumps as FDA reviewers take little issue wi... [Published FierceBiotech - Sep 10 2014]
NPS Pharma: Important Catalyst Coming Next Week [Published Seeking Alpha - Sep 03 2014]
NPS Pharma Blames Winter, Drug Stops for Weak F... [Published The Street Latest - May 08 2014]
Clementia Pharmaceuticals Inc. Appoints Francoi... [Published Marketwire - Breaking News Releases - Mar 26 2014]
NPS Pharma's hypoparathyroidism drug Natpara ge... [Published PharmaBiz - Jan 07 2014]
1
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Clementia Pharmaceuticals Inc. Appoints Francoi... [Published Marketwire - Breaking News Releases - Mar 26 2014]
Healthcare Industry Veteran Brings Deep Expertise in Developing Innovative Therapies for Patients With Rare Diseases ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.